Jens J. Holst - Concepedia

Author

Jens J. Holst

Also Known As

A Hinney, A. Nishiyama, C Holst, C. Holst, C. J. J. Tack, Cnop, Miriam, E Ehrenreich Kuhre, Elizaveta Chabanova, H J Chi, Hajjar Roger J.

2.7K

Publications

158.9K

Citations

193

H-Index

360

Concepts

All Affiliations

University of Copenhagen Rigshospitalet Novo Nordisk Foundation Hvidovre Hospital Gentofte Hospital

About

Jens J. Holst is an author at University of Copenhagen specializing in medicine, physiology, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	127	593	61.6K
2	Health Sciences	91	259	31.2K
3	Natural Sciences	19	20	2.4K
4	Education	7	7	603
5	Engineering	4	4	173

Jens J. Holst

1.4K

Publications

128.2K

Citations

180

H-Index

Page 1

	Year	Citations
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. Michael A. Nauck, Markus M. Heimesaat, Jens J. Holst, Journal of Clinical Investigation GlycobiologyPreserved Incretin ActivityPlasma GipInsulin SignalingGastrointestinal Peptide Hormone	1993	1.6K
Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. Anne Flint, Anne Raben, Arne Astrup, Journal of Clinical Investigation NutritionPromotes SatietyCaloric RestrictionExperimental NutritionGastrointestinal Peptide Hormone	1998	1.4K
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study Mette Zander, Sten Madsbad, Jan Lysgaard Madsen, The Lancet Metabolic SyndromeDiabetes ManagementGlucagon-like Peptide 1DiabetesPhysiology	2002	1.3K
Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients Michael A. Nauck, N. Kleine, C. �rskov, Diabetologia Metabolic SyndromeDiabetes ManagementBiochemistryMedicineInsulin Management	1993	1.1K
Switching from Insulin to Oral Sulfonylureas in Patients with Diabetes Due to Kir6.2 Mutations Ewan R. Pearson, Isabelle Flechtner, Pål R. Njølstad, New England Journal of Medicine	2006	979
Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition Ruud S. Kootte, Evgeni Levin, Jarkko Salojärvi, Cell Metabolism ObesityMetabolic SyndromeNutritionInsulin SensitivityDysbiosis	2017	963
Inhibition of gastric inhibitory polypeptide signaling prevents obesity Kazumasa Miyawaki, Yuichiro Yamada, Nobuhiro Ban, Nature Medicine ObesityMetabolic SyndromeGastric InhibitoryGastrointestinal Peptide HormoneMedicine	2002	941
Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans Cathrine Ørskov, L. Rabenhøj, André Wettergren, Diabetes	1994	885
Reduced Postprandial Concentrations of Intact Biologically Active Glucagon-Like Peptide 1 in Type 2 Diabetic Patients Tina Vilsbøll, Thure Krarup, Carolyn F. Deacon, Diabetes	2001	877
Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes Mellitus M. Gutniak, Cathrine Ørskov, Jens J. Holst, New England Journal of Medicine	1992	868

Page 1